In an infant starting at 2 months, how many doses of Vaxelis (DTaP‑HepB‑IPV) are required in the primary series?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaxelis Primary Series Dosing

Vaxelis (DTaP-IPV-Hib-HepB) is administered as a 3-dose primary series at 2,4, and 6 months of age when starting at 2 months old. 1, 2

Standard Dosing Schedule

  • The primary vaccination series consists of exactly 3 doses given at ages 2,4, and 6 months, as recommended by the FDA and ACIP 1, 2
  • The minimum age for the first dose is 6 weeks, but the standard schedule begins at 2 months 1, 2
  • A minimum interval of 4 weeks must occur between each dose 1, 2

Critical Timing Requirements

  • Dose 1: Given at 2 months (minimum age 6 weeks) 1, 2
  • Dose 2: Given at 4 months (minimum age 10 weeks, minimum 4-week interval from dose 1) 1, 2
  • Dose 3: Given at 6 months (minimum age 24 weeks, minimum 4-week interval from dose 2) 1, 2

Essential Hepatitis B Consideration

  • Vaxelis is NOT licensed for the birth dose of hepatitis B vaccine - infants must receive a separate monovalent hepatitis B vaccine at birth before starting the Vaxelis series 1, 2
  • If the third dose is inadvertently given before 24 weeks of age, an additional dose of hepatitis B vaccine must be administered at age ≥24 weeks to ensure adequate immune response 1, 2

Important Limitations

  • Vaxelis should NOT be used for booster doses - separate vaccines are required for the fourth DTaP dose at 15-18 months, the Hib booster at 12-15 months, and the fourth IPV dose at 4-6 years 2
  • The maximum age for any Vaxelis dose is 4 years, 364 days (do not administer on or after the fifth birthday) 1

Special Population Note

  • For American Indian/Alaska Native infants, both Vaxelis (3-dose series at 2,4,6 months) and monovalent PRP-OMP (2-dose series at 2,4 months) are now preferred options due to early protection against Hib disease 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vaxelis Dosing Guidelines for Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a 5-month-old child who missed the second dose of Vaxelis (hexavalent vaccine) receive it today and return in 4 weeks for the third dose?
What is the recommended dosing schedule, administration route, contraindications, and catch‑up protocol for Vaxelis (pentavalent diphtheria‑tetanus‑acellular pertussis‑inactivated poliovirus‑Haemophilus influenzae type b‑hepatitis B) vaccine in a healthy infant older than six weeks?
What vaccinations are given together at the 2-month visit, including Diphtheria, Tetanus, and Pertussis (DTaP), Haemophilus influenzae type b (Hib), Inactivated Poliovirus (IPV), Pneumococcal Conjugate (PCV), and Hepatitis B (HepB) vaccines?
Are Pentacel (Diphtheria, Tetanus, and Pertussis, Inactivated Poliovirus, and Haemophilus influenzae type b vaccine) and Vaxelis (Diphtheria, Tetanus, and Pertussis, Inactivated Poliovirus, and Haemophilus influenzae type b vaccine) only used in pediatric patients up to age 4?
At what age can Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) no longer be administered to children?
What is the recommended Kegel exercise protocol for an adult male without acute pelvic infection or severe pelvic pain, including technique, sets, repetitions, hold duration, contraindications, and indications for referral to pelvic‑floor physical therapy?
In a 32-year-old female with severe pelvic pain, hypotension after a motor vehicle accident and CT showing a large external pelvic hematoma with active arterial bleeding, what is the most appropriate immediate management?
How should I calculate and prescribe weight‑based medication doses, considering the patient’s age, renal and hepatic function, obesity, and other comorbidities?
What is the next treatment step for an adult with MCAS‑related tachycardia and POTS who remains symptomatic despite fexofenadine 180 mg twice daily, famotidine 20 mg twice daily, and montelukast 10 mg daily while adhering to first‑line POTS measures?
Should I restart dabigatran (Pradaxa) 150 mg twice daily now that I have been off it for one month after an unprovoked deep‑vein thrombosis without specialist follow‑up?
How should I estimate glomerular filtration rate in an African‑American patient without using race‑based equations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.